The authors discuss the molecular mechanisms whereby cancer cells shape a myeloid cell-mediated immunosuppressive tumor microenvironment and, reciprocally, how such myeloid cells affect tumor progression and immunotherapy efficiency in glioblastoma.
[Trends in Cancer]